Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Nanopharmaceuticals Llc

Clinical trials sponsored by Nanopharmaceuticals Llc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Can a Brain-Penetrating drug tackle recurrent glioblastoma? Results expected Jun 2027 (estimated)
Browse trials soon ready across all sponsors →
Not yet finished but already full! 1
Sort by
  • Can a Brain-Penetrating drug tackle recurrent glioblastoma?

    Disease control Ongoing

    This phase 1 trial tests the safety and tolerability of an experimental drug called Fb-PMT in people with recurrent glioblastoma, an aggressive brain cancer. Fb-PMT targets multiple cancer signaling pathways and is designed to cross the blood-brain barrier to reach the tumor. Res…

    Phase 1 • Sponsor: NanoPharmaceuticals LLC • Aim: Disease control

    Last updated Sep 02, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space